| |
| Device | RESOLUTE ONYX ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM |
| Generic Name | Coronary drug-eluting stent |
| Applicant | Medtronic Vascular 3576 Unocal Pl. Santa Rosa, CA 95403 |
| PMA Number | P160043 |
| Date Received | 09/27/2016 |
| Decision Date | 04/28/2017 |
| Product Code |
NIQ |
| Docket Number | 17M-2767 |
| Notice Date | 05/02/2017 |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT02412501
|
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the Resolute Onyx Zotarolimus-Eluting Coronary Stent System. This device is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions of length less than or equal to 35 mm in native coronary arteries with reference vessel diameters of 2.25 mm to 5.0 mm. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S003 S004 S001 S002 S012 S013 S007 S008 S009 S010 S024 S025 S022 S059 S060 S048 S065 S066 S067 S051 S052 S054 S062 S042 S043 S057 S069 S070 S085 S088 S079 S086 S089 S092 S093 S094 S016 S011 S017 S005 S006 S014 S015 S037 S033 S034 S035 S038 S029 S026 S027 S028 S023 S018 S019 S020 S031 S032 S021 S039 S040 S061 S063 S064 S044 S045 S071 S058 S068 S055 S056 S046 S047 S049 S050 S075 S076 S077 S078 S080 S081 S087 S073 S074 S084 S095 S096 S090 |